Meadow Creek Investment Management’s Quest Diagnostics DGX Stock Holding History

Meadow Creek Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$6.92M	Buy	64,680 +6,226	+11%	+$639K	0.14%	138
2019 Q2	$5.95M	Sell	58,454 -5,896	-9%	-$567K	0.12%	166
2019 Q1	$5.79M	Buy	64,350 +17,468	+37%	+$1.51M	0.12%	164
2018 Q4	$3.9M	Buy	46,882 +13,288	+40%	+$1.25M	0.09%	212
2018 Q3	$3.63M	Sell	33,594 -14,982	-31%	-$1.64M	0.07%	247
2018 Q2	$5.34M	Sell	48,576 -8,998	-16%	-$937K	0.11%	172
2018 Q1	$5.78M	Sell	57,574 -5,544	-9%	-$568K	0.13%	160
2017 Q4	$6.22M	Sell	63,118 -19,800	-24%	-$1.88M	0.14%	150
2017 Q3	$7.76M	Sell	82,918 -1,958	-2%	-$208K	0.18%	114
2017 Q2	$9.44M	Buy	84,876 +39,028	+85%	+$4.13M	0.23%	95
2017 Q1	$4.5M	Sell	45,848 -15,928	-26%	-$1.52M	0.11%	173
2016 Q4	$5.68M	Buy	+61,776	New	+$5.32M	0.15%	124

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Meadow Creek Investment Management's DGX Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Quest Diagnostics (DGX) stake by 11% in Q3 2019, buying an estimated $639K and bringing the position to 64,680 shares worth $6.92M. The position accounts for 0.14% of the portfolio, ranked #138.

Meadow Creek Investment Management first reported a position in DGX in Q4 2016 and has held it in 12 quarters since. The position peaked at $9.44M in Q2 2017. 677 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

Meadow Creek Investment Management held 64,680 shares of Quest Diagnostics worth $6.92M as of Q3 2019.
Meadow Creek Investment Management bought 6,226 Quest Diagnostics shares in Q3 2019, an estimated $639K.
Quest Diagnostics made up 0.14% of Meadow Creek Investment Management's portfolio in Q3 2019, its #138 holding.
Meadow Creek Investment Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's Quest Diagnostics position peaked at $9.44M in Q2 2017.
677 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.